News stories about National Health Investors (NYSE:NHI) have been trending somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned press coverage about the real estate investment trust an impact score of 46.0513073817162 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Shares of National Health Investors traded up $0.93, hitting $74.50, during trading hours on Thursday, MarketBeat Ratings reports. 138,782 shares of the company’s stock traded hands, compared to its average volume of 234,466. National Health Investors has a 12-month low of $62.71 and a 12-month high of $81.60. The firm has a market capitalization of $3.07 billion, a price-to-earnings ratio of 13.98, a PEG ratio of 3.84 and a beta of 0.46. The company has a debt-to-equity ratio of 0.88, a quick ratio of 15.21 and a current ratio of 15.21.
National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, May 8th. The real estate investment trust reported $0.92 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.34 by ($0.42). The firm had revenue of $72.75 million for the quarter, compared to the consensus estimate of $72.04 million. National Health Investors had a net margin of 53.88% and a return on equity of 11.69%. National Health Investors’s revenue was up 9.6% on a year-over-year basis. During the same period last year, the business earned $1.25 EPS. sell-side analysts forecast that National Health Investors will post 5.5 earnings per share for the current fiscal year.
Several analysts have commented on the stock. Wells Fargo & Co set a $75.00 price objective on shares of National Health Investors and gave the stock a “market perform” rating in a report on Thursday, May 31st. They noted that the move was a valuation call. Capital One Financial upgraded shares of National Health Investors from an “equal weight” rating to an “overweight” rating in a report on Friday, May 11th. Cantor Fitzgerald restated a “hold” rating and issued a $75.00 price objective on shares of National Health Investors in a report on Tuesday, May 8th. KeyCorp lowered their price objective on shares of National Health Investors from $70.00 to $60.00 and set a “sell” rating for the company in a report on Tuesday, April 17th. Finally, BMO Capital Markets set a $70.00 target price on shares of National Health Investors and gave the company a “hold” rating in a report on Monday, March 26th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $73.44.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.